TomoTherapy to Present at Three Upcoming Investment Conferences
Company Featured at Baird’s 2008 Growth Stock Conference on May 15, Craig-Hallum Institutional Investor Conference on May 20, and Citi Global Health Care Conference on May 21
MADISON, Wis. – May 14, 2008 – TomoTherapy Incorporated (NASDAQ: TOMO) today announced that management will participate in three investment community conferences in May.
On Thursday, May 15, 2008, Dr. Fred Robertson, CEO, and Steve Hathaway, CFO, will present at Baird’s 2008 Growth Stock Conference at 11:50 a.m. CT. The conference is being held at the Four Seasons Hotel in Chicago, Ill.
Robertson and Hathaway will also present at the 5th Annual Craig-Hallum Institutional Investor Conference on Tuesday, May 20, 2008. The conference takes place at the Radisson Plaza Hotel in Minneapolis, Minn.
On Wednesday, May 21, 2008, Hathaway and Del Coufal, TomoTherapy’s vice president of marketing, will present at the Citi Global Health Care Conference at 3:00 p.m. ET. The conference is being held at the Hilton Hotel in New York City, N.Y.
Live Webcasts of the Baird and Citi presentations will be available on the investor relations page of TomoTherapy.com. For those who are unable to listen to the live presentations, archives of the Webcasts will be available on the company’s site for 30 days following the presentation. Craig-Hallum’s Institutional Investor Conference is not being Webcast.
About TomoTherapy Incorporated
TomoTherapy Incorporated has developed, markets and sells the TomoTherapy® Hi·Art® treatment system, an advanced radiation therapy system for the treatment of a wide variety of cancers. The Hi·Art treatment system combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. The company’s stock is traded on the NASDAQ Global Select Market under the symbol TOMO.
14 May 2008
